DEVELOPMENT STAGES AND TREATMENT METHODS OF CHRONIC HEART FAILURE
DOI:
https://doi.org/10.55640/Keywords:
chronic heart failure, NYHA classification, ACC/AHA stages, pharmacotherapy, heart transplantation.Abstract
This article provides a comprehensive analysis of the development mechanisms, clinical progression stages, and modern treatment methods of chronic heart failure (CHF). The primary aim of the research is to clarify the pathogenesis of CHF, outline the major stages in its dynamic progression, and identify effective treatment strategies appropriate for each stage. The article examines the disease development stages based on two classification systems— the NYHA (New York Heart Association) functional classification and the ACC/AHA (American College of Cardiology/American Heart Association) staging system.Key treatment methods include lifestyle modifications, essential pharmacotherapy (ACE inhibitors, beta-blockers, MRAs, SGLT2 inhibitors), and surgical interventions, including heart transplantation. Ultimately, the article emphasizes that the goal of contemporary CHF management is not only to alleviate symptoms, but also to slow disease progression, improve quality of life, and extend life expectancy. In conclusion, chronic heart failure management is a long-term, multidisciplinary, and individualized process.
Downloads
References
.Khodjiyev, Kh.Kh., Rakhimov, M.M. Chronic Heart Failure: Pathogenesis, Clinical Features, Treatment. Tashkent: Ibn Sino Publishing, 2020.
2. Abdullayev, A.A., Karimov, Sh.I. Modern Treatment Methods of Cardiovascular Diseases. Tashkent: New Century Generation, 2021.
3. Rakhmanova, N.A., Tursunov, B.T. Standards for Diagnosis and Treatment in Cardiology. Tashkent: Medicine Publishing, 2022.
4. Yuldasheva, D.M. “Cardiac Remodeling and the Efficacy of Pharmacotherapy in Chronic Heart Failure.” Uzbekistan Cardiology Journal, 2021, No. 4, pp. 45–52.
5. Saidov, Z.S., Khasanova, M.M. “Clinical Efficacy of Novel Therapies in Chronic Heart Failure.” Medical Innovations, 2022, No. 3, pp. 28–34.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India